ALG11 | ALG11, alpha-1,2-mannosyltransferase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ALG12 | ALG12, alpha-1,6-mannosyltransferase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ALG13 | ALG13, UDP-N-acetylglucosaminyltransferase subunit | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
ALG2 | ALG2, alpha-1,3/1,6-mannosyltransferase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ALG3 | ALG3, alpha-1,3- mannosyltransferase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ALG5 | ALG5, dolichyl-phosphate beta-glucosyltransferase | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ALG8 | ALG8, alpha-1,3-glucosyltransferase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ALG9 | ALG9, alpha-1,2-mannosyltransferase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ALK | Anaplastic lymphoma receptor tyrosine kinase | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ALKBH8 | AlkB, alkylation repair homolog 8 (E. coli) | Enzymes
| | | | | Expressed in all |
AMT | Aminomethyltransferase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
ANKK1 | Ankyrin repeat and kinase domain containing 1 | Enzymes
| | | | | Tissue enhanced |
APRT | Adenine phosphoribosyltransferase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
ART1 | ADP-ribosyltransferase 1 | CD markers Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
ART3 | ADP-ribosyltransferase 3 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ART4 | ADP-ribosyltransferase 4 (Dombrock blood group) | Blood group antigen proteins CD markers Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ART5 | ADP-ribosyltransferase 5 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
AS3MT | Arsenic (+3 oxidation state) methyltransferase | Enzymes
| | | | | Tissue enriched |
ASH1L | Ash1 (absent, small, or homeotic)-like (Drosophila) | Enzymes
| | | | | Expressed in all |
ATAT1 | Alpha tubulin acetyltransferase 1 | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
ATE1 | Arginyltransferase 1 | Enzymes
| | | | | Expressed in all |
ATF2 | Activating transcription factor 2 | Enzymes Transcription factors
| | | | | Expressed in all |
ATIC | 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
ATM | Ataxia telangiectasia mutated | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ATR | Ataxia telangiectasia and Rad3 related | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
AURKA | Aurora kinase A | Cancer-related genes Enzymes Plasma proteins
| | | | | Mixed |
AURKB | Aurora kinase B | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
AURKC | Aurora kinase C | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enriched |
AWAT2 | Acyl-CoA wax alcohol acyltransferase 2 | Enzymes Predicted membrane proteins
| | | | | Not detected |
AXL | AXL receptor tyrosine kinase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Mixed |
B3GALNT1 | Beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) | Blood group antigen proteins Enzymes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
B3GALT4 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4 | Enzymes Predicted secreted proteins
| | | | | Mixed |
B3GAT1 | Beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
B3GAT2 | Beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S) | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
B3GAT3 | Beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I) | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
B3GNT1 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
B3GNT3 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
B3GNT5 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 | Enzymes
| | | | | Expressed in all |
B4GALNT1 | Beta-1,4-N-acetyl-galactosaminyl transferase 1 | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
B4GALNT3 | Beta-1,4-N-acetyl-galactosaminyl transferase 3 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
B4GALNT4 | Beta-1,4-N-acetyl-galactosaminyl transferase 4 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
B4GALT1 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
B4GALT2 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
B4GALT3 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3 | Enzymes
| | | | | Expressed in all |
B4GALT4 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 4 | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
B4GALT6 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 6 | Enzymes Predicted secreted proteins
| | | | | Mixed |
B4GALT7 | Xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
BAAT | Bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase) | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enriched |
BAZ1B | Bromodomain adjacent to zinc finger domain, 1B | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
BCAT1 | Branched chain amino-acid transaminase 1, cytosolic | Enzymes
| | | | | Tissue enhanced |